美因基因(06667)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06667 美因基因

未开盘 09-16 15:59:17

7.050

-0.075

-1.05%

最高7.125	最低7.045	成交量7.84万
今开7.125	昨收7.125	日振幅1.12%
总市值15.72亿	流通市值15.72亿	总股本2.23亿
成交额55.48万	换手率0.04%	流通股本2.23亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06667","market":"HK","secType":"STK","nameCN":"美因基因","latestPrice":7.05,"timestamp":1789545557109,"preClose":7.125,"halted":0,"volume":78400,"delay":0,"changeRate":-0.01052631578947371,"floatShares":223000000,"shares":223000000,"eps":0.136851,"marketStatus":"未开盘","change":-0.075,"latestTime":"09-16 15:59:17","open":7.125,"high":7.125,"low":7.045,"amount":554829,"amplitude":0.011228,"askPrice":6.84,"askSize":200,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.126,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789608600000},"marketStatusCode":0,"adr":0,"listingDate":1655827200000,"exchange":"SEHK","adjPreClose":7.125,"dividendRate":0.024883,"openAndCloseTimeList":[[1789522200000,1789531200000],[1789534800000,1789545600000]],"volumeRatio":0.7743974708197569,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06667","defaultTab":"news","newsList":[{"id":"1164611820","title":"美因基因回购6.64万股股份，耗资约47.00万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1164611820","media":"公告速递","labels":["shareholding","SGX"],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164611820?lang=zh_cn&edition=full","pubTime":"2026-09-16 20:33","pubTimestamp":1789561998,"startTime":"0","endTime":"0","summary":"2026年9月16日，美因基因有限公司发布翌日披露报表，公告于2026年9月16日通过香港联交所场内回购66,400股普通股，占回购前已发行股本约0.0298%。本次回购价格介乎每股7.065港元至7.105港元，总耗资约47.00万港元。回购完成后，公司于2026年9月16日的已发行股份数为223,091,400股，库藏股数为1,208,800股，合计股本总数224,300,200股。公司并披露回购授权于2026年5月21日获通过，目前可动用的购回授权总数为22,430,020股，至今已于交易所及其他证券交易所合计回购股份1,208,800股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因回购6.64万股股份，耗资约47.00万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667839019","title":"美因基因(06667)9月16日斥资47万港元回购6.64万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667839019","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667839019?lang=zh_cn&edition=full","pubTime":"2026-09-16 20:28","pubTimestamp":1789561707,"startTime":"0","endTime":"0","summary":"智通财经APP讯，美因基因(06667)发布公告，于2026年9月16日斥资47万港元回购6.64万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1497062.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154062848","title":"美因基因9月15日回购9.68万股股份，耗资约69.07万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1154062848","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154062848?lang=zh_cn&edition=full","pubTime":"2026-09-15 19:41","pubTimestamp":1789472487,"startTime":"0","endTime":"0","summary":"美因基因有限公司于2026年9月15日发布公告，披露该公司于同日进行了股份回购操作，共回购普通股股份96,800股，约占回购前已发行股本的0.0434%。本次回购每股价格介乎港币7.125元至港币7.14元，合计支付约690,720.00港元。公司回购授权的决议于2026年5月21日获通过，授权回购最高总数为22,430,020股。公司在公告中确认，本次回购已遵守香港联合交易所有限公司的上市规则以及相关法例的规定。公告由董事姜晶签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因9月15日回购9.68万股股份，耗资约69.07万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179889056","title":"美因基因购回8.26万股股份，总额约59.16万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1179889056","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179889056?lang=zh_cn&edition=full","pubTime":"2026-09-14 19:56","pubTimestamp":1789386976,"startTime":"0","endTime":"0","summary":"美因基因有限公司于2026年9月14日发布公告，披露其当日于香港联合交易所通过场内交易方式回购股份。本次回购合计8.26万股，占回购前公司已发行股份约0.037%，每股回购价格区间介乎每股7.15港元至7.165港元，合计耗资约59.16万港元。本次回购后，下一次发行或出售库存股份仍受相关暂止期规定约束至2026年10月14日。公司确认，本次回购已获董事会正式授权批准，并严格遵守香港联交所证券上市规则及相关法律法规。公告由董事姜晶签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因购回8.26万股股份，总额约59.16万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667663203","title":"美因基因(06667)9月14日斥资约59.16万港元回购8.26万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667663203","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667663203?lang=zh_cn&edition=full","pubTime":"2026-09-14 19:54","pubTimestamp":1789386869,"startTime":"0","endTime":"0","summary":"智通财经APP讯，美因基因(06667)发布公告，于2026年9月14日该公司斥资约59.16万港元回购8.26万股，回购价格为每股7.15至7.165港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495846.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193216334","title":"美因基因：俞熔减持，好仓比例降至17.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=1193216334","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193216334?lang=zh_cn&edition=full","pubTime":"2026-09-14 17:50","pubTimestamp":1789379458,"startTime":"0","endTime":"0","summary":"俞熔于2026年9月10日以每股均价5.5000港元卖出美因基因股份100.00万股，涉资约550.00万港元。俞熔此次减持前持有美因基因好仓4079.51万股，占比17.88%；减持后持股量为3979.51万股，好仓比例降至17.74%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f7700173111443e192ac74957e46cb69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666452727","title":"美因基因购回5.54万股普通股 涉资约39.76万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2666452727","media":"财闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666452727?lang=zh_cn&edition=full","pubTime":"2026-09-11 20:52","pubTimestamp":1789131120,"startTime":"0","endTime":"0","summary":"9月11日，美因基因(06667.HK)于2026年9月11日在香港联交所购回55400股普通股，每股最高购回价HKD7.195，最低购回价HKD7.16，付出的价格总额为HKD397,578。购回股份拟持作库存股份，拟注销数目为0。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-11/doc-inirnhsa7399083.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160036354","title":"美因基因9月11日回购5.54万股，耗资约39.76万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1160036354","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1160036354?lang=zh_cn&edition=full","pubTime":"2026-09-11 19:42","pubTimestamp":1789126955,"startTime":"0","endTime":"0","summary":"美因基因有限公司于2026年9月11日向香港联合交易所提交的翌日披露报表显示，公司于当日在港交所回购普通股55,400股，占当日前已发行股份总数223,392,600股的约0.0248%。本次回购价格区间为每股7.16港元至7.195港元，总计耗资397,578港元。美因基因于2026年5月21日通过购回相关授权，可回购股份总数为22,430,020股，截至目前已累计购回963,000股，占购回授权通过当日已发行股份总数的0.4293%。公司确认本次股份购回已遵守相关上市规则及适用法律法规。公告由董事姜晶签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"美因基因9月11日回购5.54万股，耗资约39.76万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666003598","title":"美因基因(06667.HK)9月10日耗资39.2万港元回购5.46万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666003598","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666003598?lang=zh_cn&edition=full","pubTime":"2026-09-10 19:57","pubTimestamp":1789041426,"startTime":"0","endTime":"0","summary":"格隆汇9月10日丨美因基因(06667.HK)发布公告，2026年9月10日耗资39.2万港元回购5.46万股，回购价格每股7.16-7.195港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260910/32366512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1219","06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167593026","title":"美因基因回购54,600股股份，耗资约39.25万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1167593026","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167593026?lang=zh_cn&edition=full","pubTime":"2026-09-10 19:31","pubTimestamp":1789039882,"startTime":"0","endTime":"0","summary":"美因基因有限公司2026年9月10日发布公告称，公司于当日通过香港联交所场内回购54,600股普通股，约占回购前公司已发行股本的0.0244%。回购价格介乎每股7.16港元至7.195港元，合计耗资约39.25万港元。本次回购完成后，公司已发行股本为223,392,600股，库藏股数量增至907,600股，总已发行股份数仍为224,300,200股。回购后30天内公司将暂不进行新的股份发行或出售库藏股，直至2026年10月10日。公司强调已遵守香港联交所主板上市规则及相关法律法规，公告由公司董事姜晶签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因回购54,600股股份，耗资约39.25万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129599233","title":"美因基因回购85,000股股份，耗资约61.56万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1129599233","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129599233?lang=zh_cn&edition=full","pubTime":"2026-09-09 19:45","pubTimestamp":1788954345,"startTime":"0","endTime":"0","summary":"美因基因于2026年9月9日公告称，公司于香港联交所场内回购股份85,000股，约占回购前已发行股本的0.038%。本次回购每股价格介乎港币7.055元至7.29元，总耗资约61.56万港元。本次回购完成后，公司已发行股本变更为223,447,200股，库藏股数量变更至853,000股，合计已发行股份总数为224,300,200股。根据公告，2026年5月21日公司已通过回购授权，可回购股份总数为22,430,020股，截至目前已累计回购股份853,000股。公司确认已遵守香港联合交易所有限公司证券上市规则及其他相关法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因回购85,000股股份，耗资约61.56万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666580132","title":"美因基因(06667.HK)9月9日斥资61.56万港元回购8.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666580132","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666580132?lang=zh_cn&edition=full","pubTime":"2026-09-09 19:41","pubTimestamp":1788954091,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193411084","title":"美因基因更新8月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1193411084","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193411084?lang=zh_cn&edition=full","pubTime":"2026-09-01 17:35","pubTimestamp":1788255314,"startTime":"0","endTime":"0","summary":"美因基因有限公司于2026年9月1日发布截至2026年8月31日的股份变动月报表。公告显示，公司在报告期内已发行股本及注册股本无变化，股本保持稳定。根据公告，公司的法定/注册股本仍为500,000,000股，面值每股0.0001美元，对应注册股本总额50,000美元，与上月末数据一致。此外，公告显示，公司于本月并无股份期权或股权激励计划的授出、行使或失效情形，也未发生可兑换债券及其他相关股本变动。本次月报由公司董事姜晶签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664300884","title":"美因基因中期净利润同比下降9.2% 毛利率下降40.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664300884","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664300884?lang=zh_cn&edition=full","pubTime":"2026-09-01 09:07","pubTimestamp":1788224820,"startTime":"0","endTime":"0","summary":"8月31日，美因基因（06667）发布截至2026年6月30日止六个月的中期业绩公告。报告期内，公司实现营业收入1.93亿元，较2025年同期的8130万元同比增长136.8%。然而，净利润为2480万元，同比下降9.2%，主要由于产品结构变动导致毛利率下降。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609013860920148.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609013860920148.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663800903","title":"美因基因(06667.HK)发布中期业绩 收入1.92亿元 同比大幅增长136.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663800903","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663800903?lang=zh_cn&edition=full","pubTime":"2026-08-31 22:20","pubTimestamp":1788186012,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126391746","title":"美因基因2026年中期营收1.93亿元，经调整净利润24.75百万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1126391746","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126391746?lang=zh_cn&edition=full","pubTime":"2026-08-31 22:06","pubTimestamp":1788185214,"startTime":"0","endTime":"0","summary":"2026年上半年，美因基因实现营收约1.93亿元，较上年同期81.3百万元增长136.8%。经调整净利润约24.75百万元，同比下降9.2%。财报显示，本期美因基因综合毛利约63.68百万元，同比上升5.9%；综合毛利率为33.1%，上年同期为74.0%。期内，研发投入约7.1百万元，相比上一年同期的8.2百万元有所减少，占本期营收的3.69%；销售及分销开支约14.41百万元，同比上升38.3%；行政开支约10.76百万元，同比提升9.4%。消费级基因检测服务实现收入约76.83百万元，同比增长1.3%；","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"美因基因2026年中期营收1.93亿元，经调整净利润24.75百万元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127883694","title":"美因基因（06667）拟于8月31日召开董事会审议2026年中期业绩及股息安排","url":"https://stock-news.laohu8.com/highlight/detail?id=1127883694","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127883694?lang=zh_cn&edition=full","pubTime":"2026-08-03 20:15","pubTimestamp":1785759335,"startTime":"0","endTime":"0","summary":"美因基因有限公司（06667）8月3日公告称，公司董事会已订于2026年8月31日（星期一）召开会议，届时将审议并批准集团截至2026年6月30日止六个月的中期业绩公告及其发布事宜，并考虑是否宣派中期股息。会议还将处理其他事项。\n公告显示，截至本公告日期，公司董事会成员包括：执行董事俞熔博士、林琳女士（兼董事会主席）及姜晶女士；非执行董事郭美玲女士；独立非执行董事张影博士、贾庆丰先生及谢丹博士。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149370687","title":"美因基因7月股份变动月报表，股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1149370687","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149370687?lang=zh_cn&edition=full","pubTime":"2026-08-03 20:02","pubTimestamp":1785758525,"startTime":"0","endTime":"0","summary":"8月3日，美因基因有限公司公布2026年7月股份变动月报表。公告显示，截至2026年7月31日，公司法定/注册股本为500,000,000股普通股，每股面值0.0001美元，对应注册股本为50,000美元，较上月底无变化。月报未列示任何新增股份发行、股份期权或其他股权激励安排的变动，也无可换股票据、认股权证或其他相关协议的发行记录。公司声明当前公众持股量符合相关规定，并确认已遵守香港联交所《上市规则》及相关法律法规。本次公告由公司董事姜晶签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143204963","title":"美因基因披露6月股份变动月报表，累计回购25,400股","url":"https://stock-news.laohu8.com/highlight/detail?id=1143204963","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143204963?lang=zh_cn&edition=full","pubTime":"2026-08-03 19:45","pubTimestamp":1785757556,"startTime":"0","endTime":"0","summary":"美因基因有限公司于2026年8月3日公布2026年6月股份变动月报表。期末公司法定/注册股本维持在500,000,000股普通股，面值USD 0.0001，合计注册股本USD 50,000。期间，公司无新增发行股本，但于2026年6月先后四次回购合计25,400股股份。其中包括于6月17日以每股HKD 6.19回购18,800股，6月22日以HKD 7.02回购200股，6月23日以HKD 7.00回购2,000股，以及6月30日以HKD 7.11回购4,400股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128594791","title":"美因基因回购10.82万股股份，总额约76.61万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1128594791","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128594791?lang=zh_cn&edition=full","pubTime":"2026-07-28 17:56","pubTimestamp":1785232571,"startTime":"0","endTime":"0","summary":"2026年7月28日，美因基因有限公司发布公告称，于香港联合交易所回购股份10.82万股，占该公司于回购前已发行股本约0.0484%，每股回购价格介乎7.08港元至7.10港元，涉资共计约76.61万港元。回购完成后，公司已发行股本从原有的223,640,400股减少至223,532,200股，库藏股从659,800股增至768,000股，合计股份总数保持在224,300,200股。公告显示，本次股份购回依照公司于2026年5月21日通过的购回授权进行，授权可购回股份总数为22,430,020股。公告由董事姜晶签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因回购10.82万股股份，总额约76.61万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0174},{"period":"1month","weight":-0.0042},{"period":"3month","weight":0.0071},{"period":"6month","weight":0.0407},{"period":"1year","weight":0.0031},{"period":"ytd","weight":0.0031}],"compareEarnings":[{"period":"1week","weight":-0.0222},{"period":"1month","weight":-0.0291},{"period":"3month","weight":0.033},{"period":"6month","weight":-0.0223},{"period":"1year","weight":-0.0652},{"period":"ytd","weight":-0.0358}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"美因基因有限公司是一家主要提供基因检测服务及癌症筛查服务的投资控股公司。该公司主要通过消费级基因检测分部和癌症筛查服务分部开展业务。该公司的检测服务包括脑健康评估检测套餐、营养吸收能力评估检测套餐、帕金森病风险评估、全面癌症风险评估套餐、心脑血管疾病风险评估套餐等。该公司也提供体外诊断（IVD）管线产品，包括消费级基因检测产品和疾病筛查产品。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.166378},{"month":2,"riseRate":0.75,"avgChangeRate":0.055076},{"month":3,"riseRate":0,"avgChangeRate":-0.048593},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.010548},{"month":5,"riseRate":0.666667,"avgChangeRate":0.005636},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.015012},{"month":7,"riseRate":0.5,"avgChangeRate":0.008854},{"month":8,"riseRate":0.25,"avgChangeRate":-0.060544},{"month":9,"riseRate":0,"avgChangeRate":-0.126018},{"month":10,"riseRate":0,"avgChangeRate":-0.078395},{"month":11,"riseRate":0.333333,"avgChangeRate":0.114508},{"month":12,"riseRate":0.666667,"avgChangeRate":0.22092}],"exchange":"SEHK","name":"美因基因","nameEN":"MEGA GENOMICS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"美因基因(06667)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供美因基因(06667)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"美因基因,06667,美因基因股票,美因基因股票老虎,美因基因股票老虎国际,美因基因行情,美因基因股票行情,美因基因股价,美因基因股市,美因基因股票价格,美因基因股票交易,美因基因股票购买,美因基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"美因基因(06667)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供美因基因(06667)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}